These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31486499)

  • 1. Long noncoding RNA OR3A4 promotes the migration and invasion of melanoma through the PI3K/AKT signaling pathway.
    Wu J; Zhou MY; Yu XP; Wu Y; Xie PL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6991-6996. PubMed ID: 31486499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA OR3A4 facilitates cell proliferation and migration in colorectal cancer through the Wnt/β-catenin signaling pathway.
    Sun W; Chen GR; Wang J; Yu XY; Hao XF; Hu MY
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5360-5366. PubMed ID: 32495870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of the expression of the lncRNA MIAT inhibits melanoma migration and invasion through the PI3K/AKT signaling pathway.
    Yang Y; Zhang Z; Wu Z; Lin W; Yu M
    Cancer Biomark; 2019; 24(2):203-211. PubMed ID: 30614798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.
    Liao Z; Zhao J; Yang Y
    Mol Med Rep; 2018 May; 17(5):7313-7318. PubMed ID: 29568965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
    Lu D; Sun L; Li Z; Mu Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA OR3A4 promotes metastasis of ovarian cancer via inhibiting KLF6.
    Guo FF; Jiang MM; Hong LL; Qiao B; Lin XM; Xu WY; Fu XQ
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2360-2365. PubMed ID: 30964160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA SNHG7 promotes migration and invasion of melanoma via upregulating SOX4.
    Zhang C; Zhu B; Li XB; Cao YQ; Yang JC; Li X; Liu YX; Wang YB
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4828-4834. PubMed ID: 31210315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway.
    Gao H; Liu R; Sun X
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8000-8010. PubMed ID: 31599425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB; Wang JA; Lv RQ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA OR3A4 participates in the angiogenesis of hepatocellular carcinoma through modulating AGGF1/akt/mTOR pathway.
    Li W; Fu Q; Man W; Guo H; Yang P
    Eur J Pharmacol; 2019 Apr; 849():106-114. PubMed ID: 30710550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
    Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
    J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA OR3A4 is associated with poor prognosis of human non-small cell lung cancer and regulates cell proliferation via up-regulating SOX4.
    Zhong M; Wang WL; Yu DJ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6524-6530. PubMed ID: 31378892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis.
    Yao X; Yan C; Zhang L; Li Y; Wan Q
    Medicine (Baltimore); 2018 Apr; 97(16):e0473. PubMed ID: 29668625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs.
    Guo X; Liu Y; Zheng X; Han Y; Cheng J
    Life Sci; 2020 May; 248():117445. PubMed ID: 32081664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
    Liu M; Gao X; Liu CL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1.
    Sun Y; Cao FL; Qu LL; Wang ZM; Liu XY
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1459-1467. PubMed ID: 30840267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway.
    Zhang L; Wang Y; Su H
    Neoplasma; 2020 Jul; 67(4):762-772. PubMed ID: 32726126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA H19 binds VGF and promotes pNEN progression via PI3K/AKT/CREB signaling.
    Ji M; Yao Y; Liu A; Shi L; Chen D; Tang L; Yang G; Liang X; Peng J; Shao C
    Endocr Relat Cancer; 2019 Jul; 26(7):643-658. PubMed ID: 31117050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.